ARCHIVES

NCI Criticized For Delays In Development Of New Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | January 24, 1975

Download PDF Visit The Full Archive

Related Articles

Gallo’s Deputy Removed Pending Investigation

January 11, 1991

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

Center Directors To Rewrite 5-Year Plan With Little Staff Help

March 9, 1990

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

March 1, 2013

In Brief: Berlin Leaving Northwestern To Become Zubrod’s Deputy at Miami; Four Center Director Jobs Open

August 7, 1987